G1/S-specific cyclin-D1 (CCND1) Antibody

Product Graph
299€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
G1/S-specific cyclin-D1 (CCND1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx402346
tested applications
ELISA, WB

Description

G1/S-specific cyclin-D1 (CCND1) Antibody is a Recombinant Rabbit Monoclonal antibody for the detection of Human, Mouse CCND1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
G1/S-specific cyclin-D1 (CCND1)
Host
Rabbit
Reactivity
Human, Mouse
Recommended Dilution
WB: 1/500 - 1/5000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG
Expression
Recombinant
Purification
Purified by affinity chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA, WB
Buffer
PBS, pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P24385
Background
Antibody anti-CCND1
Status
RUO

Descripción

Related Products

EH0970

Human CCND1 (G1/S-specific cyclin-D1) ELISA Kit

Ver Producto
EM0414

Mouse CCND1 (G1/S-specific cyclin-D1) ELISA Kit

Ver Producto
FNab02124

CCND1 antibody

CCND1(cyclin D1), also known as PRAD1 or BCL1, belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. CCND1 forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. The CCND1 gene, located on 11q13 has been reported to be overexpressed in mantle cell lymphoma(MCL) due to the chromosomal translocation. CCND1 has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Over-expression of CCND1 is known to correlate with the early onset of cancer and risk of tumor progression and metastasis.

Ver Producto